Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
Clinical trial NCT00028483 · TERMINATED
Trial details
- NCT number
- NCT00028483
- Sponsor
- Seagen Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-10-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.